Slackening Demand Weighs on Outlook
Jabil Circuit reported mixed results, but attention mainly focused on the weak guidance . First-quarter profit will be no more than $0.62 a share, below the $0.67 expected by analysts. Revenue will also be weak as governments cut spending on clean technologies. JBL drops 6 percent before the bell on my tradeMONSTER platform.
Copart Rallies on Strong Results
Copart reported fourth-quarter earnings of $0.35, compared with the $0.33 expected by analysts. Revenue of $226.6 million also beat the $221 million consensus estimate. CPRT, which runs a market for scrapped vehicles, climbs almost 7 percent in early trading.
FDA Move Gives a Boost to Sucampo Pharma
Sucampo Pharmaceuticals announced that the Food & Drug Administration will give priority review to its Amitiza drug, used by cancer patients on painkillers. SCMP rallies 9 percent in the premarket.

